REYKJAVIK, ICELAND (June 2, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Robert Wessman, Alvotech’s Founder and Executive Chairman, and Dr. Balaji V. Prasad, Chief Strategy Officer, will participate in the upcoming investor conferences in June as follows:Jefferies Global Healthcare Conference in New York – fireside chat on Thursday, June 4, 2026 at 9:20 am ET (13:20 GMT) Goldman Sachs 47th Annual Global Healthcare Conference in Miami – fireside chat Monday, June 8, 2026 at 8:40 am ET (12:40 GMT) UBS Virtual Generics and Biosimilars Day – fireside chat on Wednesday, June 10, 2026 at 10:30 am ET (14:30 GMT)The live audio webcasts will be available to investors and the...

With U.S. grid interconnection timelines stretching three to seven years, data centers are losing billions in delayed capacity. The 2.5MWh Power Hub is engineered for rapid deployment, delivering megawatt-scale power within days of arrival. Scaling from 1.2 MWh to 4 MWh, the 2.5MWh Power Hub series serves AI data centers, industrial build-outs, and mission-critical facilities, replacing years of infrastructure planning with a single factory-integrated unit that plugs in and powers on. Built on the same architecture behind more than 250 MWh of Xos energy storage already operating in commercial service across North America, the Power Hub is a productized platform with a proven track record, not a launch promise.LOS ANGELES, June 02, 2026 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS) (“Xos” or the “Company”), a leader in electric...

WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) — Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June:2026 Jefferies Global Healthcare Conference, fireside chat on Wednesday, June 3, 2026 at 4:20 p.m. ET in New York Goldman Sachs 47th Annual Global Healthcare Conference, fireside chat on Monday, June 8, 2026 at 8:40 a.m. ET in MiamiA live webcast of each presentation will be available in the Investors section of Crescent’s website at https://investors.crescentbiopharma.com/events-presentations, and a replay will be accessible for 90 days. About Crescent Biopharma Crescent Biopharma’s...

HOUSTON, TX, June 02, 2026 (GLOBE NEWSWIRE) — Abundia Global Impact Group, Inc. (NYSE American: AGIG) (“Abundia” or the “Company”), a low-carbon energy solutions company focused on converting biomass and plastics waste into high-value low-carbon fuels, announced today that the Company will participate in the 16th Annual ROTH London Conference being held June 16-18, 2026, at the Four Seasons Hotel London at Park Lane in London, UK. Abundia’s CEO Ed Gillespie and CFO Lucie Harwood will be available for one-on-one meetings with institutional investors throughout the conference. This international forum provides management with an opportunity to discuss the Company’s significant progress toward advancing its Cedar Port project, commercialization strategy and plans for additional projects both in the US and Europe, feedstock...

CHANDLER, Ariz., June 02, 2026 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the 2026 Evercore Global TMT Conference on Wednesday, June 3, 2026 at 1:20 p.m. (Pacific Time). Presenting for the Company will be Mr. Steve Sanghi, President, CEO and Chair, and Mr. Eric Bjornholt, Senior Vice President and Chief Financial Officer. A live webcast of the presentation will be made available by Evercore, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies of SEC filings can...

LA JOLLA, Calif., June 02, 2026 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that on June 1, 2026, the Compensation Committee of Equillium’s Board of Directors granted an inducement award consisting of nonstatutory stock options to purchase a total of 145,000 shares of common stock to a new employee under Equillium’s 2024 Inducement Plan. The Compensation Committee approved the stock option as an inducement material to such employee’s employment in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option has an exercise price per share equal to $3.08, Equillium’s closing stock price on June 1, 2026, and will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary...

Everyday Advocacy provides people living with endocrine and endocrine-related conditions with education, support, and tools to facilitate more impactful healthcare team interactions Steering committee of five leading patient organizations to guide program with authentic perspectives and insights into most significant patient needs SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the launch of Everyday Advocacy, a new initiative designed to support patient education, self-advocacy, and connection within endocrine disease communities. “Crinetics is led by a conviction that meaningful progress for endocrine disease treatment begins with listening to patients and understanding their unique lived experiences,” said Jacqueline Kirby, Chief Corporate Affairs Officer of Crinetics....